S&P 500   3,948.36 (+-0.01%)
DOW   32,119.88 (+0.05%)
QQQ   308.06 (-0.55%)
AAPL   158.42 (-0.32%)
MSFT   277.58 (-0.03%)
META   203.98 (-0.15%)
GOOGL   104.49 (-1.05%)
AMZN   97.11 (-1.62%)
TSLA   188.27 (-2.05%)
NVDA   264.96 (-2.56%)
NIO   8.92 (-3.78%)
BABA   85.78 (-0.86%)
AMD   97.41 (-2.86%)
T   18.47 (+0.05%)
F   11.42 (+0.00%)
MU   60.77 (-0.93%)
CGC   1.90 (-0.52%)
GE   91.72 (+0.14%)
DIS   93.26 (-2.68%)
AMC   4.45 (-0.45%)
PFE   40.17 (-0.02%)
PYPL   72.92 (+0.50%)
NFLX   326.37 (+1.87%)
S&P 500   3,948.36 (+-0.01%)
DOW   32,119.88 (+0.05%)
QQQ   308.06 (-0.55%)
AAPL   158.42 (-0.32%)
MSFT   277.58 (-0.03%)
META   203.98 (-0.15%)
GOOGL   104.49 (-1.05%)
AMZN   97.11 (-1.62%)
TSLA   188.27 (-2.05%)
NVDA   264.96 (-2.56%)
NIO   8.92 (-3.78%)
BABA   85.78 (-0.86%)
AMD   97.41 (-2.86%)
T   18.47 (+0.05%)
F   11.42 (+0.00%)
MU   60.77 (-0.93%)
CGC   1.90 (-0.52%)
GE   91.72 (+0.14%)
DIS   93.26 (-2.68%)
AMC   4.45 (-0.45%)
PFE   40.17 (-0.02%)
PYPL   72.92 (+0.50%)
NFLX   326.37 (+1.87%)
S&P 500   3,948.36 (+-0.01%)
DOW   32,119.88 (+0.05%)
QQQ   308.06 (-0.55%)
AAPL   158.42 (-0.32%)
MSFT   277.58 (-0.03%)
META   203.98 (-0.15%)
GOOGL   104.49 (-1.05%)
AMZN   97.11 (-1.62%)
TSLA   188.27 (-2.05%)
NVDA   264.96 (-2.56%)
NIO   8.92 (-3.78%)
BABA   85.78 (-0.86%)
AMD   97.41 (-2.86%)
T   18.47 (+0.05%)
F   11.42 (+0.00%)
MU   60.77 (-0.93%)
CGC   1.90 (-0.52%)
GE   91.72 (+0.14%)
DIS   93.26 (-2.68%)
AMC   4.45 (-0.45%)
PFE   40.17 (-0.02%)
PYPL   72.92 (+0.50%)
NFLX   326.37 (+1.87%)
S&P 500   3,948.36 (+-0.01%)
DOW   32,119.88 (+0.05%)
QQQ   308.06 (-0.55%)
AAPL   158.42 (-0.32%)
MSFT   277.58 (-0.03%)
META   203.98 (-0.15%)
GOOGL   104.49 (-1.05%)
AMZN   97.11 (-1.62%)
TSLA   188.27 (-2.05%)
NVDA   264.96 (-2.56%)
NIO   8.92 (-3.78%)
BABA   85.78 (-0.86%)
AMD   97.41 (-2.86%)
T   18.47 (+0.05%)
F   11.42 (+0.00%)
MU   60.77 (-0.93%)
CGC   1.90 (-0.52%)
GE   91.72 (+0.14%)
DIS   93.26 (-2.68%)
AMC   4.45 (-0.45%)
PFE   40.17 (-0.02%)
PYPL   72.92 (+0.50%)
NFLX   326.37 (+1.87%)
ETR:SBS

Stratec - SBS Stock Forecast, Price & News

€65.90
0.00 (0.00%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
€65.00
▼
€66.70
50-Day Range
€65.40
▼
€90.60
52-Week Range
€64.70
▼
€130.60
Volume
15,270 shs
Average Volume
6,253 shs
Market Capitalization
$799.37 million
P/E Ratio
28.04
Dividend Yield
1.44%
Price Target
€90.75

Stratec MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
37.7% Upside
€90.75 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Stratec in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.58 out of 5 stars

See Top Rated MarketRank™ Stocks Here

SBS stock logo

About Stratec (ETR:SBS) Stock

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

SBS Stock News Headlines

March 24, 2023 | americanbankingnews.com
Stratec (ETR:SBS) Given a €80.00 Price Target by Warburg Research Analysts
March 20, 2023 | uk.finance.yahoo.com
Stratec SE (SBS.SG)
March 24, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
March 18, 2023 | americanbankingnews.com
Stratec (ETR:SBS) PT Set at €87.00 by Hauck Aufhäuser Investment Banking
March 15, 2023 | msn.com
German Market Update: Three Shares to Buy Today
March 10, 2023 | marketwatch.com
Shares in Stratec Fall After Sales Decline, Lower Margin Forecast
January 4, 2023 | finance.yahoo.com
Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)
December 21, 2022 | finance.yahoo.com
Stratec SE's (ETR:SBS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
March 24, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
December 15, 2022 | markets.businessinsider.com
EQS-News: STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
December 7, 2022 | finance.yahoo.com
Investors Met With Slowing Returns on Capital At Stratec (ETR:SBS)
December 1, 2022 | uk.finance.yahoo.com
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE
December 1, 2022 | fool.com
Stratec Se (ETR: SBS)
November 23, 2022 | finance.yahoo.com
Stratec (ETR:SBS) investors are sitting on a loss of 33% if they invested a year ago
November 6, 2022 | finance.yahoo.com
Stratec SE (ETR:SBS) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
November 3, 2022 | markets.businessinsider.com
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
November 1, 2022 | finance.yahoo.com
Institutional investors own a significant stake of 38% in Stratec SE (ETR:SBS)
October 20, 2022 | marketwatch.com
Stratec Shares Fall After Sales Guidance Cut
October 14, 2022 | finance.yahoo.com
Stratec SE (SBS.DE)
September 13, 2022 | uk.finance.yahoo.com
STRATEC Biomedical AG (SBS.DE)
September 9, 2022 | reuters.com
SBSG.DE - Stratec SE | Stock Price & Latest News | Reuters
August 27, 2022 | wsj.com
Stratec SE
August 10, 2022 | markets.businessinsider.com
DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
May 20, 2022 | uk.finance.yahoo.com
STRATEC’S ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARD
May 20, 2022 | markets.businessinsider.com
DGAP-News: STRATECS ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARD
May 5, 2022 | markets.businessinsider.com
DGAP-News: STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022
March 30, 2022 | markets.businessinsider.com
DGAP-News: STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR
See More Headlines
Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
ETR:SBS
CUSIP
N/A
CIK
N/A
Web
www.stratec.com
Phone
+49-7082-79160
Fax
N/A
Employees
1,282
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€90.75
High Stock Price Forecast
€119.00
Low Stock Price Forecast
€77.00
Forecasted Upside/Downside
+37.7%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
€2.35
Trailing P/E Ratio
28.04
Forward P/E Ratio
18.31
P/E Growth
10.43
Net Income
$28.33 million
Net Margins
10.51%
Pretax Margin
N/A
Return on Equity
13.67%
Return on Assets
6.87%

Debt

Debt-to-Equity Ratio
38.79
Current Ratio
3.48
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$269.57 million
Price / Sales
2.97
Cash Flow
€2.76 per share
Price / Cash Flow
23.85
Book Value
€17.69 per share
Price / Book
3.73

Miscellaneous

Outstanding Shares
12,130,000
Free Float
N/A
Market Cap
$799.37 million
Optionable
Optionable
Beta
0.32

Key Executives

  • Mr. Marcus Wolfinger (Age 56)
    Chairman of Board of Management & CEO
    Comp: $972k
  • Dr. Robert Siegle (Age 56)
    Director of Fin. & HR and Member of Board of Management
    Comp: $775k
  • Dr. Claus Vielsack (Age 56)
    Director of Product Devel. & Member of Board of Management
    Comp: $601k
  • Mr. Hermann Leistner (Age 77)
    Founder & Advisor
  • Mr. Jan Keppeler
    Head of Investor Relations, Sustainability & Corp. Communications
  • Mr. Andre Loy
    Director of Corp. Communications
  • Mr. Roland Utz
    Head of Supply Chain Management & Sr. VP

Key Competitors

View All Competitors













SBS Stock - Frequently Asked Questions

What is Stratec's stock price forecast for 2023?

0 Wall Street research analysts have issued 1 year target prices for Stratec's shares. Their SBS share price forecasts range from €77.00 to €119.00. On average, they anticipate the company's stock price to reach €90.75 in the next twelve months. This suggests a possible upside of 37.7% from the stock's current price.
View analysts price targets for SBS or view top-rated stocks among Wall Street analysts.

How have SBS shares performed in 2023?

Stratec's stock was trading at €81.10 on January 1st, 2023. Since then, SBS shares have decreased by 18.7% and is now trading at €65.90.
View the best growth stocks for 2023 here.

Is Stratec a good dividend stock?

Stratec (ETR:SBS) pays an annual dividend of €0.95 per share and currently has a dividend yield of 1.45%. The dividend payout ratio is 40.43%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Stratec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO), Berkshire Hills Bancorp (BHLB), ASGN (ASGN), Apptio (APTI) and Anadarko Petroleum (APC).

What is Stratec's stock symbol?

Stratec trades on the ETR under the ticker symbol "SBS."

What is Stratec's stock price today?

One share of SBS stock can currently be purchased for approximately €65.90.

How much money does Stratec make?

Stratec (ETR:SBS) has a market capitalization of $799.37 million and generates $269.57 million in revenue each year. The company earns $28.33 million in net income (profit) each year or €2.35 on an earnings per share basis.

How many employees does Stratec have?

The company employs 1,282 workers across the globe.

How can I contact Stratec?

Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The official website for the company is www.stratec.com. The company can be reached via phone at +49-7082-79160.

This page (ETR:SBS) was last updated on 3/24/2023 by MarketBeat.com Staff